XORTX is turning into another FSD Pharma Just before XORTX made its debut in the NASDAQ, thieir consolidated shares where trading at nearly $6.00 a share.
However, over the last month, their shares have plummeted to just over $3.00 a share.
This is raising concerns that XORTX is turning into another FSD Pharma, a former medicinal cannabis company now specializing in biotechnology whom is a victim of lies and pumping.